Recent in Regulatory (page 31 of 31)

REACH Update: SIEF Tasks and Registration Requirements

Substance Information Exchange Forums (SIEFs) are operational and critical for data-sharing and the subsequent preparation of joint registration dossiers. A SIEF is established when companies have agreed that their substance is the same.

FDA Finds Harmful Bacteria in Antimicrobial Products

The US Food and Drug Administration (FDA) has warned consumers to avoid the use of Clarcon skin products. According to the FDA, there is a risk of bacterial contamination associated with the products.

'Nessie' and The Precautionary Principle

Academia continues to conduct experiments demonstrating that nanoparticles do not penetrate into the deeper layers of the skin but skeptics and activist groups do not accept this evidence.

Recent ATPs and Their Effect in the EU and Abroad

The recast of the directive, known as the 8th Amendment, has been proposed. This amendment currently is in review by the European Parliament and Council of Ministers. If an agreement is reached, the personal care industry will see many sweeping changes, as reported in the June 2008 edition of this column.

FDA Recalls Face Paint Due to Adverse Reactions

The FDA has learned of a cluster of adverse events in children exposed to various colors of the face paint. All exposures occurred on the same day at an organized event and included rashes, itchiness, burning sensation, and swelling where the face paints were applied.

REACH Update: ECHA Urges Companies to Organize SIEFs

In a fact sheet dated Apr. 24, 2009, the ECHA reminded REACH preregistrants that it is urgent to become involved in SIEF activities as soon as possible since deadlines for registration are extremely tight.

Can't find what you're looking for? Try searching, or looking through past issues.